User profiles for Christina Hu
 | Christina HuHead of the ZOE Health Study (MACantab) Verified email at joinzoe.com Cited by 4465 |
[HTML][HTML] Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Background The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1
nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials. We …
nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials. We …
[HTML][HTML] Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based …
Background COVID-19 vaccines show excellent efficacy in clinical trials and effectiveness
in real-world data, but some people still become infected with SARS-CoV-2 after vaccination. …
in real-world data, but some people still become infected with SARS-CoV-2 after vaccination. …
[HTML][HTML] Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance …
Background The SARS-CoV-2 variant of concern, omicron, appears to be less severe than
delta. We aim to quantify the differences in symptom prevalence, risk of hospital admission, …
delta. We aim to quantify the differences in symptom prevalence, risk of hospital admission, …
[HTML][HTML] Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2
Background In children, SARS-CoV-2 infection is usually asymptomatic or causes a mild
illness of short duration. Persistent illness has been reported; however, its prevalence and …
illness of short duration. Persistent illness has been reported; however, its prevalence and …
[HTML][HTML] COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study
Background With the surge of new SARS-CoV-2 variants, countries have begun offering
COVID-19 vaccine booster doses to high-risk groups and, more recently, to the adult population …
COVID-19 vaccine booster doses to high-risk groups and, more recently, to the adult population …
[HTML][HTML] Self-reported COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups in the United States and United Kingdom
Worldwide, racial and ethnic minorities have been disproportionately impacted by COVID-19
with increased risk of infection, its related complications, and death. In the initial phase of …
with increased risk of infection, its related complications, and death. In the initial phase of …
[HTML][HTML] Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study
…, L Polidori, S Selvachandran, C Hu… - The Lancet Public …, 2021 - thelancet.com
Background The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in
England. We aimed to investigate whether increases in the proportion of infections with this …
England. We aimed to investigate whether increases in the proportion of infections with this …
[HTML][HTML] Diet quality and risk and severity of COVID-19: a prospective cohort study
Objective Poor metabolic health and unhealthy lifestyle factors have been associated with
risk and severity of COVID-19, but data for diet are lacking. We aimed to investigate the …
risk and severity of COVID-19, but data for diet are lacking. We aimed to investigate the …
[HTML][HTML] Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake
Background: Racial and ethnic minorities have been disproportionately impacted by COVID-19.
In the initial phase of population-based vaccination in the United States (US) and United …
In the initial phase of population-based vaccination in the United States (US) and United …
Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app
Background Mental health issues have been reported after SARS-CoV-2 infection. However,
comparison to prevalence in uninfected individuals and contribution from common risk …
comparison to prevalence in uninfected individuals and contribution from common risk …
